Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Immatics N.V. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $100 Billion
- Q4 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Immatics N.V. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 22,701 shares of IMTX stock, worth $113,505. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,701
Previous 18,224
24.57%
Holding current value
$113,505
Previous $207,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IMTX
# of Institutions
92Shares Held
82.1MCall Options Held
313KPut Options Held
377K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.6MShares$53 Million0.05% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$46.9 Million2.23% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$36.4 Million0.57% of portfolio
-
Rtw Investments, LP New York, NY6.54MShares$32.7 Million0.76% of portfolio
-
Vestal Point Capital, LP New York, NY6.28MShares$31.4 Million2.65% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $381M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...